-
Shanghai intellectual property moves chime with World IP Day
April 30, 2024
East China's Shanghai recently reaffirmed its commitment to intellectual property, or IP on the occasion of the 24th World Intellectual Property Day.
-
US patents, trademarks boss visits Shanghai IP body
April 25, 2024
In a significant move to bolster intellectual property rights, Kathi Vidal, director of the United States Patent and Trademark Office, or USPTO, met with officials from the Shanghai Intellectual Property Administration, or SIPA, in East China's Shanghai on April 19.
-
Shanghai vice-mayor holds IP talks with top US official
April 25, 2024
Shanghai Vice-Mayor Xie Dong met in East China's Shanghai on April 18 with Kathi Vidal, director of the United States Patent and Trademark Office – the USPTO – to discuss promoting intellectual property, or IP rights and innovation.
-
Shanghai unveils measures for premier IP business environment
April 19, 2024
Shanghai Intellectual Property Administration has released a plan to continuously enhance the premier international Intellectual Property (IP) business environment.
-
Shanghai district's rule of law spurs business confidence
April 19, 2024
The Fengxian district of East China's Shanghai recently gave a presentation on its commitment to the rule of law at a manufacturing investment event.
-
SIPA director meets chief executive of Singapore IP Office
April 15, 2024
In a bid to boost cooperation in the field of intellectual property or IP, the Shanghai Intellectual Property Administration (SIPA) welcomed a delegation from Singapore on April 12.
-
Shanghai builds international first-class business environment for IP
April 15, 2024
East China's Shanghai has taken the bold step of reforming its intellectual property or IP landscape with the release of a comprehensive plan to create a world-class business environment.
-
Senior Shanghai official meets Merck pharma group executive
April 11, 2024
In the run-up to the Boao Forum for Asia Annual Meeting 2024, a significant meeting took place between a senior official from East China's Shanghai and a top executive from German pharma giant Merck KGaA.